Decitabine (in combination with BP1002): Clinical Trials

1 recruiting. 1 Phase 1.

By phase and status

Phase	Trials	Status
Phase 1	1	Recruiting 1

Follow Decitabine (in combination with BP1002): new trials by email Literature Review of Decitabine (in combination with BP1002) trials Research Report on Decitabine (in combination with BP1002)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML) BP1002; Liposomal Bcl-2 Antisense Oligodeoxynucleotide, Decitabine (in combination with BP1002) - Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory	Phase 1	Recruiting	Bio-Path Holdings, Inc.	48	2022-08-16	2025-03-10

Conditions studied

Leukemia, Myeloid, Acute (1)

Sponsors

Bio-Path Holdings, Inc. (1)

Countries

United States (1)

Top investigators

Gail J Roboz, MD (1)